Form D · Biotechnology
Quadrant Biosciences Inc
Syracuse, NY · CIK 0001651239
Offering snapshot reported Nov 2, 2023 · SEC filing
- Reported sold
- Yet to sell Offering amount: $25.4M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 2, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Aug 8, 2023 | Initial | $3,500,000 | No comparison | 6 | SEC filing |
| Jan 23, 2020 | Initial | $2,300,000 | No comparison | 20 | SEC filing |
| Jun 27, 2019 | Initial | $450,000 | No comparison | 6 | SEC filing |
| Dec 13, 2016 | Initial | $2,080,000 | No comparison | 30 | SEC filing |
| Apr 14, 2016 | Amendment | $3,602,450 | $25,000vs Apr 13, 2016 | 36 | SEC filing |
| Apr 13, 2016 | Amendment | $3,577,450 | $3,142,450vs Aug 19, 2015 | 35 | SEC filing |
| Aug 19, 2015 | Initial | $435,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-496380
Source: Form D, filed Nov 2, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Erica Ash | Executive |
| Patrick Bailey | Executive |
| Richard Bongo | Director, Executive |
| Andrew Brindle | Executive |
| Randy Carpenter | Executive |
| Peter Cohen | Director |
| James Croke | Director, Executive |
| Ira Fedder | Director |
| Scott Giambalvo | Executive |
| Nicholas Gianadda | Executive |
| Bryan Greene | Executive |
| Cindy Dowd Greene | Director |
| Chris Horacek | Executive |
| David Mac Lean | Executive |
| Benjamin Perry | Executive |
| Alexander Rajan | Executive |
| Alexander Rajan, Ph D | Executive |
| Andrew Rock | Director |
| Mary Ann Tyszko | Director |
| Mary K. Tyszko | Director |
| Richard Uhlig | Director, Executive |
| Kayla Wagner | Executive |
| Wade West | Director, Executive |
| Gary Wade West, Jr. | Director |
| Jeremy Williams | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
505 Irving Avenue Suite 3100 A B
Syracuse, NY, 13210
Syracuse, NY, 13210